FDA Advisers Back Novavax COVID-19 Shots As New US Option

podcast: CBS Baltimore

Next, the FDA must decide whether to authorize the vaccine made by latecomer Novavax, a protein vaccine that's made with a more conventional technology than today's U.S. options.
Publicado con Parlarispa

Lista de episodios - [audio]